Provided by Tiger Trade Technology Pte. Ltd.

Theravance Biopharma

17.02
-0.0200-0.12%
Post-market: 17.020.00000.00%19:30 EDT
Volume:683.74K
Turnover:11.64M
Market Cap:882.12M
PE:16.29
High:17.05
Open:17.03
Low:17.02
Close:17.04
52wk High:21.03
52wk Low:13.08
Shares:51.83M
Float Shares:25.86M
Volume Ratio:1.86
T/O Rate:2.64%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.05
EPS(LYR):2.06
ROE:20.91%
ROA:1.33%
PB:3.04
PE(LYR):8.26

Loading ...

Jun 10, 2023

Major Issues Report

Form 8-K - Current report
Jun 08, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 18, 2023

[Rev.]Quaterly Report

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
May 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 10, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2023

Major Issues Report

8-K - Current report
May 03, 2023

Major Issues Report

8-K - Current report
Apr 17, 2023

Major Issues Report

8-K - Current report
Apr 14, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 12, 2023

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Apr 11, 2023

Major Issues Report

8-K - Current report
Mar 13, 2023

Major Issues Report

8-K - Current report
Mar 01, 2023

Major Issues Report

8-K/A [Amend] - Current report
Mar 01, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 28, 2023

Major Issues Report

8-K - Current report
Feb 27, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals